/VEEV
VEEV Stock - Veeva Systems Inc.
Healthcare|Medical - Healthcare Information ServicesNYSE
$221.86+1.72%
+$3.76 (+1.72%) • Dec 19
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.14
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.78
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+33.2%upside
Target: $295.52
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VEEV
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$219.64 – $224.08
TARGET (TP)$295.57
STOP LOSS$204.11
RISK/REWARD1:4.2
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.05
52W High$310.50
52W Low$201.54
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.75B | $2.36B | $2.16B | $1.85B | $1.47B |
| Gross Profit | $2.05B | $1.69B | $1.55B | $1.35B | $1.06B |
| Gross Margin | 74.5% | 71.3% | 71.7% | 72.8% | 72.1% |
| Operating Income | $691.43M | $429.33M | $459.09M | $505.50M | $377.79M |
| Net Income | $714.14M | $525.71M | $487.71M | $427.39M | $380.00M |
| Net Margin | 26.0% | 22.2% | 22.6% | 23.1% | 25.9% |
| EPS | $4.41 | $3.27 | $3.14 | $2.79 | $2.52 |
Company Overview
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
12
71%
Hold / Neutral
4
24%
Sell / Underperform
1
6%
Analyst Consensus🟢 Bullish
12 Bullish5 Neutral/Bearish
Price Targets
$245
Average Target
↑ 10.5% Upside
Now
$170
Low
$245
Average
$380
High
Based on 25 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 12th 2025 | KeyBanc Capital Markets | Downgrade | Sector Weight | - |
| November 13th 2025 | BMO Capital Markets | Initiation | Market Perform | $300 |
| October 7th 2025 | TD Cowen | Upgrade | Buy | $380 |
| September 8th 2025 | JP Morgan | Upgrade | Overweight | $330 |
| May 29th 2025 | Needham | Reiterated | Buy | $300← $270 |
| January 23rd 2025 | Goldman | Downgrade | Sell | $200← $261 |
| December 20th 2024 | Stephens | Initiation | Overweight | $280 |
| December 4th 2024 | Mizuho | Initiation | Outperform | $275 |
| November 19th 2024 | Scotiabank | Initiation | Sector Perform | $235 |
| October 8th 2024 | Exane BNP Paribas | Initiation | Outperform | $286 |
| August 27th 2024 | Citigroup | Reiterated | Buy | $273← $256 |
| July 9th 2024 | BTIG Research | Initiation | Buy | $240 |
| October 25th 2023 | Wells Fargo | Upgrade | Overweight | $229← $211 |
| October 13th 2023 | Jefferies | Initiation | Buy | $265 |
| June 28th 2023 | Morgan Stanley | Downgrade | Underweight | $181 |
Earnings History & Surprises
VEEVBeat Rate
100%
Last 18 quarters
Avg Surprise
+7.5%
EPS vs Estimate
Beats / Misses
18/0
Last 12 quarters
Latest EPS
$2.04
Q4 2025
EPS Surprise History
Q1 24
+6.2%
$1.38vs$1.30
Q2 24
+5.6%
$1.50vs$1.42
Q3 24
+5.9%
$1.62vs$1.53
Q4 24
+10.8%
$1.75vs$1.58
Q1 25
+8.7%
$1.74vs$1.60
Q2 25
+13.2%
$1.97vs$1.74
Q3 25
+4.7%
$1.99vs$1.90
Q4 25
+4.6%
$2.04vs$1.95
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 26, 2026 | — | — | — | — |
Q1 2026 | Mar 4, 2026 | $1.92 | — | — | — |
Q4 2025 | Nov 20, 2025 | $1.95 | $2.04 | +4.6% | ✓ BEAT |
Q3 2025 | Aug 27, 2025 | $1.90 | $1.99 | +4.7% | ✓ BEAT |
Q2 2025 | May 28, 2025 | $1.74 | $1.97 | +13.2% | ✓ BEAT |
Q1 2025 | Mar 5, 2025 | $1.60 | $1.74 | +8.7% | ✓ BEAT |
Q4 2024 | Dec 5, 2024 | $1.58 | $1.75 | +10.8% | ✓ BEAT |
Q3 2024 | Aug 28, 2024 | $1.53 | $1.62 | +5.9% | ✓ BEAT |
Q2 2024 | May 30, 2024 | $1.42 | $1.50 | +5.6% | ✓ BEAT |
Q1 2024 | Feb 29, 2024 | $1.30 | $1.38 | +6.2% | ✓ BEAT |
Q4 2023 | Dec 6, 2023 | $1.28 | $1.34 | +4.7% | ✓ BEAT |
Q3 2023 | Aug 30, 2023 | $1.12 | $1.21 | +8.0% | ✓ BEAT |
Q2 2023 | May 31, 2023 | $0.79 | $0.91 | +15.2% | ✓ BEAT |
Q1 2023 | Mar 1, 2023 | $1.04 | $1.15 | +10.6% | ✓ BEAT |
Q4 2022 | Dec 1, 2022 | $1.07 | $1.13 | +5.6% | ✓ BEAT |
Q3 2022 | Aug 31, 2022 | $1.01 | $1.03 | +2.0% | ✓ BEAT |
Q2 2022 | Jun 1, 2022 | $0.92 | $0.99 | +7.6% | ✓ BEAT |
Q1 2022 | Mar 2, 2022 | $0.88 | $0.90 | +2.3% | ✓ BEAT |
Q4 2021 | Dec 1, 2021 | $0.88 | $0.97 | +10.2% | ✓ BEAT |
Q3 2021 | Sep 1, 2021 | $0.86 | $0.94 | +9.3% | ✓ BEAT |
Latest News
Veeva Systems shares are trading lower after Keybanc downgraded the stock from Overweight to Sector Weight.
📉 NegativeBenzinga•Dec 12, 2025, 01:45 PM
Keybanc Downgrades Veeva Systems to Sector Weight
📉 NegativeBenzinga•Dec 12, 2025, 11:43 AM
Veeva Systems Launches Veeva AI Agents For Vault CRM Including Free Text Voice And Pre Call Agent
📈 PositiveBenzinga•Dec 3, 2025, 12:11 PM
Wells Fargo Maintains Overweight on Veeva Systems, Lowers Price Target to $333
➖ NeutralBenzinga•Nov 25, 2025, 03:39 PM•Also:
Citigroup Maintains Buy on Veeva Systems, Lowers Price Target to $319
➖ NeutralBenzinga•Nov 24, 2025, 06:33 PM•Also:
Veeva Systems' Veeva Vault CRM Selected By Roche Pharmaceuticals Under Expanded Collaboration
📈 PositiveBenzinga•Nov 24, 2025, 12:18 PM•Also:
Canaccord Genuity Maintains Hold on Veeva Systems, Lowers Price Target to $280
➖ NeutralBenzinga•Nov 21, 2025, 06:38 PM•Also:
Barclays Maintains Overweight on Veeva Systems, Lowers Price Target to $305
➖ NeutralBenzinga•Nov 21, 2025, 05:44 PM•Also:
Veeva nears six-month low despite Q3 beat, guidance hike
📉 NegativeSeeking Alpha•Nov 21, 2025, 05:12 PM
UBS Maintains Neutral on Veeva Systems, Lowers Price Target to $280
➖ NeutralBenzinga•Nov 21, 2025, 04:21 PM•Also:
Baird Maintains Outperform on Veeva Systems, Raises Price Target to $319
📈 PositiveBenzinga•Nov 21, 2025, 02:29 PM
Veeva Systems shares are trading lower. The company reported Q3 financial results.
📉 NegativeBenzinga•Nov 21, 2025, 01:46 PM
Needham Reiterates Buy on Veeva Systems, Maintains $355 Price Target
📈 PositiveBenzinga•Nov 21, 2025, 11:02 AM
BTIG Reiterates Buy on Veeva Systems, Maintains $340 Price Target
📈 PositiveBenzinga•Nov 21, 2025, 10:39 AM
Veeva Systems shares are trading lower. The company reported Q3 financial results.
📉 NegativeBenzinga•Nov 20, 2025, 09:39 PM
Veeva Systems Raises FY2026 Adj EPS Guidance from $7.78 to $7.93 vs $7.81 Est; Raises FY2026 Sales Guidance from $3.134B-$3.140B to $3.166B-$3.169B vs $3.141B Est
📈 PositiveBenzinga•Nov 20, 2025, 09:09 PM
Veeva Systems Sees Q4 Adj EPS $1.92 vs $1.90 Est; Sees Sales $807.000M-$810.000M vs $800.575M Est
📈 PositiveBenzinga•Nov 20, 2025, 09:08 PM
Veeva Sys Q3 Adj. EPS $2.04 Beats $1.95 Estimate, Sales $811.200M Beat $792.816M Estimate
📈 PositiveBenzinga•Nov 20, 2025, 09:06 PM
BMO Capital Initiates Coverage On Veeva Systems with Market Perform Rating, Announces Price Target of $300
➖ NeutralBenzinga•Nov 13, 2025, 10:01 AM
Needham Reiterates Buy on Veeva Systems, Maintains $355 Price Target
📈 PositiveBenzinga•Oct 17, 2025, 10:32 AM
Frequently Asked Questions about VEEV
What is VEEV's current stock price?
Veeva Systems Inc. (VEEV) is currently trading at $221.86 per share. The stock has moved +1.72% today.
What is the analyst price target for VEEV?
The average analyst price target for VEEV is $295.57, based on 1 analyst.
What sector is Veeva Systems Inc. in?
Veeva Systems Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NYSE exchange.
What is VEEV's market cap?
Veeva Systems Inc. has a market capitalization of $36.47 billion, making it a large-cap company.
Does VEEV pay dividends?
No, Veeva Systems Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorA
Agilent Technologies, Inc.
$137.24
Mkt Cap: $38.9B
ARGX
argenx SE
$854.99
Mkt Cap: $52.3B
BDX
Becton, Dickinson and Company
$195.59
Mkt Cap: $56.3B
BRKR
Bruker Corporation
$46.48
Mkt Cap: $7.1B
CAH
Cardinal Health, Inc.
$202.95
Mkt Cap: $48.2B
EW
Edwards Lifesciences Corporation
$85.66
Mkt Cap: $50.3B
GEHC
GE HealthCare Technologies Inc.
$82.89
Mkt Cap: $37.9B
HLN
Haleon plc
$9.90
Mkt Cap: $44.9B
IDXX
IDEXX Laboratories, Inc.
$700.34
Mkt Cap: $55.9B
IQV
IQVIA Holdings Inc.
$220.66
Mkt Cap: $37.6B
Explore stocks similar to VEEV for comparison